scholarly journals P549. Short and long term therapeutic Efficacy of Oral Nutritional Therapy in pediatric Crohn's Disease ; A Single Center Experience

2015 ◽  
Vol 9 (suppl 1) ◽  
pp. S353-S354
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Therapeutic Efficacy ◽  
Nutritional Therapy ◽  
Single Center ◽  
Single Center Experience ◽  
Short And Long Term

Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease

2006 ◽  
Vol 38 (6) ◽  
pp. 381-387 ◽  
Author(s):  
R. Berni Canani ◽  
G. Terrin ◽  
O. Borrelli ◽  
M.T. Romano ◽  
F. Manguso ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Therapeutic Efficacy ◽  
Nutritional Therapy ◽  
Short And Long Term ◽  
Paediatric Crohn’S Disease

Usefulness of Thiopurine Monotherapy for Crohn’s Disease in the Era of Biologics: A Long-Term Single-Center Experience

2018 ◽  
Vol 64 (3) ◽  
pp. 875-879 ◽  
Author(s):  
Cristina Suárez Ferrer ◽  
Yago González-Lama ◽  
Irene González-Partida ◽  
Marta Calvo Moya ◽  
Isabel Vera Mendoza ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Single Center ◽  
Single Center Experience

scholarly journals Management of Crohn’s disease in an immunosuppressed COVID-19-positive patient: safety-driven prioritisation of nutritional therapy as a bridge to restarting immunosuppression

2021 ◽  
Vol 14 (3) ◽  
pp. e239404
Author(s):  
Clare Harris ◽  
Richard James Harris ◽  
Louise Downey ◽  
Markus Gwiggner
Keyword(s):  
Risk Factors ◽  
Inflammatory Bowel Disease ◽  
Patient Safety ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Nutritional Therapy ◽  
Interleukin 12 ◽  
Inflammatory Bowel ◽  
Term Maintenance

Active inflammatory bowel disease (IBD), combined immunosuppression and corticosteroid therapy have all been identified as risk factors for a poor outcome in COVID-19 infection. The management of patients with both COVID-19 infection and active IBD is therefore complex. We present the case of a 31-year-old patient with Crohn’s disease, on dual immunosuppression with infliximab and mercaptopurine presenting with inflammatory small bowel obstruction and COVID-19 infection. The case highlights the use of nutritional therapy, which remains underused in the management of adults with IBD, to manage his flare acutely. Following negative SARS-CoV-2 PCR testing and SARS-CoV-2 IgG testing confirming an antibody response, ustekinumab (anti-interleukin 12/23) was prescribed for long-term maintenance.

Sign in / Sign up

Export Citation Format

Share Document